Research Article

OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data

Table 6

Distribution and association of OGG1 mutations with smoking status in breast cancer patients.

Mutation/exon
Chr3 (GRCh37)
Patients
Smokers (%)Nonsmokers (%)ORa (95%CI), b value

g.9792260 ins_T Intron 14 (4.6)30 (12.4)0.34 (0.12 to 1.0), 0.05
g.9793680G>A Intron 3 (rs55846930)5 (5.7)14 (5.8)1.0 (0.35 to 2.84), 1.0
g.9793748G>A Intron 31 (1.1)13 (5.4)0.2 (0.03 to 1.59), 0.13
g.9798336T>G Intron 52 (2.3)08 (3.3)0.7 (0.14 to 3.31), 0.64
g.9798349T>A Intron 55 (5.7)29 (12.0)0.45 (0.17 to 1.19), 0.1
g.9792109delT splice site Intron 1 14 (16.1)12 (5.0)3.67 (1.6 to 8.3), 0.002
g.9798307T>G
Splice site Intron 5
016 (6.6)0.16 (0.02 to 1.26), 0.08
g.9798502T>G
Splice site Intron 6
2 (2.3)16 (6.6)0.33 (0.07 to 1.48), 0.1
g.9800972T>G
Splice site Intron 7a
15 (17.2)21 (8.7)2.19 (1.07 to 4.48), 0.03
g.9798848G>A 3′UTR4 (4.6)33 (7.8)0.3 (0.1 to 0.88), 0.03
g.9798896T>C 3′UTR09 (10.3)39 (16.1)0.6 (0.28 to 1.3), 0.2
g.9793544T>G Exon 3, Val159Gly2 (2.3)16 (6.6)0.3 (0.07 to 1.47), 0.15
g.9796483G>A Exon 4, Gly221Arg (TMP_ESP_3_9796483)4 (4.6)18 (7.4)0.6 (0.2 to 1.8), 0.3
g.9798773C>G Exon 6d, Ser326Cys
(rs1052133) (CM993185)
17 (19.5)07 (2.9)8.1 (3.2 to 20.4), <0.0001
g.9807669G>A Exon 8 Trp375STOP3 (3.4)14 (5.8)0.6 (0.16 to 2.1), 0.4

aOR: odds ratio; CI: confidence interval. aORs for logistic regression analysis. b is considered statistically significant, by -test for trend.